Skip to main content
. 2018 Sep 19;16(6):4457–4462. doi: 10.3892/etm.2018.6777

Figure 1.

Figure 1.

Evaluation of stem cell surface marker expression using CD44, CD73, CD90, CD14 and CD34. The percentages of CD44+, CD73+, CD90+, CD14+ and CD34+ cells were 100, 99.5, 99.9, 0.1 and 1.8%, respectively.